Visits: 2505, Avg visit time (secs): 229,07 Back to Index
| Page | Hits | Percent |
|---|---|---|
| 889 | 35,49% | |
| /recipients.html | 309 | 12,34% |
| /cr grant/efsd-clinres-recipients.html | 147 | 5,87% |
| /lifescan/efsd-lifescan-recipients.html | 145 | 5,79% |
| /lilly/efsd-lilly-recipients.html | 63 | 2,51% |
| /msd/efsd-msd-recipients.html | 54 | 2,16% |
| /efsd-jdrf-novo/efsd-jdrf-novo-t1-recipients.html | 52 | 2,08% |
| /lilly/efsd-cds-lilly-recipients.html | 42 | 1,68% |
| /pfizer/efsd-pfizer-recipients.html | 41 | 1,64% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 38 | 1,52% |
| /novo-t2/efsd-novo-t2-recipients.html | 36 | 1,44% |
| Page | Hits | Percent |
|---|---|---|
| /exit.htm | 1056 | 42,16% |
| /sanofi-aventis/macrovascular/efsd-sanofi-aventis-cvd-recipients.html | 143 | 5,71% |
| /bms/efsd-bms-recipients.html | 117 | 4,67% |
| /lilly/efsd-cds-lilly-recipients.html | 106 | 4,23% |
| /programmes.html | 75 | 2,99% |
| /lilly/efsd-lilly-recipients.html | 57 | 2,28% |
| /gsk/efsd-gsk-recipients.html | 51 | 2,04% |
| /lifescan/efsd-lifescan-recipients.html | 51 | 2,04% |
| /dcure/efsd-dcure-recipients.html | 45 | 1,80% |
| /cr grant/efsd-clinres-recipients.html | 40 | 1,60% |
| /home.html | 34 | 1,36% |